PREMIER Biosoft and PamGene International BV form an alliance

23-Feb-2007 - PREMIER Biosoft International announced an alliance with PamGene International B.V. to develop a software product for designing custom MLPA® oligonucleotide probes for use with PamChip® microarrays. Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method for assessing tens to ...

PamGene Platform Adopted for Kinase Drug R&D Program

Collaboration with Johnson & Johnson Pharmaceutical Research & Development

13-Mar-2006 - PamGene International BV and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica NV have announced significant progress in their kinase profiling collaboration. After extensive evaluation, PamGene's microarray-based biochemical kinase activity ...

PamGene Licenses Its Microarray Platform to the University of Nottingham

13-Jul-2004 - Den Bosch, The Netherlands. PamGene International BV has today announced the licensing of its 3-Dimensional, Flow-Through Microarray Platform to Nottingham University, England. This service licence, which includes the sale of a PamGene 4-array PamStation(TM) will enable the University to develop ...

Innogenetics partners with PamGene to develop its new generation multi parameter diagnostic platform

01-Jun-2004 - Gent (Belgium) and Den Bosch (the Netherlands) - Innogenetics and PamGene International today announced an agreement whereby Innogenetics gains access to PamGene's microarray technology platform for the development of its next generation nucleic acid and protein-based tests. By combining ...